Wen-Ping Guo1, Qing Min2, Wei-Wei Gu3, Liang Yu4, Xiao Xiao1, Wei-Bing Yi3, Hong-Liang Li1, Bei Huang4, Jun-Li Li5, Ya-Jun Dai1, Jian Xia6, Jie Liu1, Bei Li1, Ben-Hong Zhou7, Minglun Li8, Hong-Xi Xu9, Xuan-Bin Wang10,11, Wen-Yuan Shi12. 1. Renmin Hospital at Intensive Care Unit, Emergency Room, Laboratory of Chinese Herbal Pharmacology of Oncology Center, and Department of Traditional Chinese Medicine; Hubei Key Laboratory of Wudang Local Chinese Medicine Research; Biomedical Research Institute; School of Basic Medicine, Hubei University of Medicine, Shiyan, 442000, Hubei Province, China. 2. School of Pharmacy, Hubei University of Science and Technology, 88 Xianning Road, Xianning, 437100, Hubei Province, China. 3. Shiyan Center for Disease Prevention and Control, 86 Tianjin Road, Shiyan, 442000, Hubei Province, China. 4. Department of Pharmacy and Department of Spleen-Stomach, Xiaogan Hospital of Traditional Chinese Medicine, 249 Huaiyin Road, Xiaogan, 432000, Hubei Province, China. 5. Xiangyang Hospital, Hubei University of Medicine, 15 Jiefang Road, Xiangyang, 441000, Hubei Province, China. 6. Emergency Center, Zhongnan Hospital, Wuhan University, 169 Donghu Road, Wuhan, 430071, Hubei Province, China. 7. Department of Pharmacy, Renmin Hospital, Wuhan University, 99 Zhangzhidong Road, Wuhan, 430060, China. 8. Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistraße 15, Munich, 81377, Germany. 9. Shuguang Hospital; School of Pharmacy, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai, 201203, China. xuhongxi88@gmail.com. 10. Renmin Hospital at Intensive Care Unit, Emergency Room, Laboratory of Chinese Herbal Pharmacology of Oncology Center, and Department of Traditional Chinese Medicine; Hubei Key Laboratory of Wudang Local Chinese Medicine Research; Biomedical Research Institute; School of Basic Medicine, Hubei University of Medicine, Shiyan, 442000, Hubei Province, China. wangxb@hbmu.edu.cn. 11. Emergency Center, Zhongnan Hospital, Wuhan University, 169 Donghu Road, Wuhan, 430071, Hubei Province, China. wangxb@hbmu.edu.cn. 12. Renmin Hospital at Intensive Care Unit, Emergency Room, Laboratory of Chinese Herbal Pharmacology of Oncology Center, and Department of Traditional Chinese Medicine; Hubei Key Laboratory of Wudang Local Chinese Medicine Research; Biomedical Research Institute; School of Basic Medicine, Hubei University of Medicine, Shiyan, 442000, Hubei Province, China. 470803618@qq.com.
Abstract
BACKGROUND: More than 210,000 medical workers have fought against the outbreak of Coronavirus Disease 2019 (COVID-19) in Hubei in China since December 2019. However, the prevalence of mental health problems in frontline medical staff after fighting COVID-19 is still unknown. METHODS: Medical workers in Wuhan and other cities in Hubei Province were invited to participate a cross-sectional and convenience sampling online survey, which assessed the prevalence of anxiety, insomnia, depression, and post-traumatic stress disorder (PTSD). RESULTS: A total of 1,091 responses (33% male and 67% female) were valid for statistical analysis. The prevalence was anxiety 53%, insomnia 79%, depression 56%, and PTSD 11%. Healthcare workers in Wuhan were more likely to face risks of anxiety (56% vs. 52%, P = 0.03) and PTSD (15% vs. 9%, P = 0.03) than those in other cities of Hubei. In terms of educational attainment, those with doctoral and masters' (D/M) degrees may experience more anxiety (median of 7.0, [interquartile range (IQR) 2.0-8.5] vs. median 5.0 [IQR 5.0-8.0], P = 0.02) and PTSD (median 26.0 [IQR 19.5-33.0] vs. median 23.0 [IQR 19.0-31.0], P = 0.04) than those with lower educational degrees. CONCLUSIONS: The mental problems were an important issue for the healthcare workers after COVID-19. Thus, an early intervention on such mental problems is necessary for healthcare workers.
BACKGROUND: More than 210,000 medical workers have fought against the outbreak of Coronavirus Disease 2019 (COVID-19) in Hubei in China since December 2019. However, the prevalence of mental health problems in frontline medical staff after fighting COVID-19 is still unknown. METHODS: Medical workers in Wuhan and other cities in Hubei Province were invited to participate a cross-sectional and convenience sampling online survey, which assessed the prevalence of anxiety, insomnia, depression, and post-traumatic stress disorder (PTSD). RESULTS: A total of 1,091 responses (33% male and 67% female) were valid for statistical analysis. The prevalence was anxiety 53%, insomnia 79%, depression 56%, and PTSD 11%. Healthcare workers in Wuhan were more likely to face risks of anxiety (56% vs. 52%, P = 0.03) and PTSD (15% vs. 9%, P = 0.03) than those in other cities of Hubei. In terms of educational attainment, those with doctoral and masters' (D/M) degrees may experience more anxiety (median of 7.0, [interquartile range (IQR) 2.0-8.5] vs. median 5.0 [IQR 5.0-8.0], P = 0.02) and PTSD (median 26.0 [IQR 19.5-33.0] vs. median 23.0 [IQR 19.0-31.0], P = 0.04) than those with lower educational degrees. CONCLUSIONS: The mental problems were an important issue for the healthcare workers after COVID-19. Thus, an early intervention on such mental problems is necessary for healthcare workers.
Authors: Rodolfo Rossi; Valentina Socci; Francesca Pacitti; Giorgio Di Lorenzo; Antinisca Di Marco; Alberto Siracusano; Alessandro Rossi Journal: JAMA Netw Open Date: 2020-05-01